More treatments with pressurized intraperitoneal aerosol chemotherapy (PIPAC) lead to better survival outcomes for patients with unresectable peritoneal surface malignancies (PSMs). Patients receiving 3 or more PIPAC procedures showed significantly improved survival. Disease progression (56%) was the main reason for stopping treatment, signaling the need for ongoing evaluation of therapy effectiveness. Surgeons should consider the […]
Category: General Surgery
Postoperative complications don’t impact survival after esophagectomy for cancer.
In a study of 541 patients with esophageal cancer undergoing neoadjuvant therapy, complications like pneumonia and anastomotic leakage showed no significant effect on overall survival across treatment arms. The shift from open to thoracoscopic esophagectomy reduced the prognostic impact of complications, with hazard ratios for overall survival decreasing significantly. Minimally invasive techniques may enhance patient […]
Endoscopic Necrosectomy: No Major Differences Found
Upfront endoscopic necrosectomy (UEN) and step-up endoscopic necrosectomy (SUEN) show similar outcomes for walled-off pancreatic necrosis, impacting how you approach patient management. No significant difference in clinical success (RR: 1.04) or technical success (RR: 1.27) between UEN and SUEN. Patient safety outcomes, including post-procedural bleeding (RR: 0.66) and recurrence (RR: 0.71), were comparable. Individualized treatment […]
Biliary Stents for Bile Leaks After Fenestrated Cholecystectomy Show No Difference
This study examines the effectiveness of different biliary stents for treating bile leaks post-fenestrated cholecystectomy, revealing significant implications for patient management. PCBL resolution rates were similar across stent types: 93.8% for 10 fr stents, 92.3% for 7 fr stents, and 88.9% for fully covered self-expanding metal stents. Plastic stents, including single and double pigtail options, […]
Rural Patients Prefer Specialist Surgeons in Cancer Care
Rural patients prioritize access to specialized surgical care within hub-and-spoke cancer networks. 53% of patients prefer a specialist surgeon and are willing to travel for a high-volume team. 39% prefer in-person visits, while 8% want to limit travel for their care. Surgeons should tailor services to align with these patient preferences for better outcomes. Four […]
Neoadjuvant GOLP Improves Outcomes in High-Risk Cholangiocarcinoma
Neoadjuvant GOLP therapy significantly enhances event-free survival in patients with resectable high-risk intrahepatic cholangiocarcinoma. Median event-free survival was 18.0 months with GOLP, compared to 8.7 months in the control group (p<0.001). Overall survival at 24 months was 79% for the neoadjuvant group vs. 61% for controls (hazard ratio 0.43). Expect lower-grade adverse events overall, with […]
Global Surgery Progress Stalled: Alarming Indicator Gaps
Surgeons need to know that 39% of countries provide timely access to essential surgery, underscoring a significant global shortfall in surgical care. Only 50.3% of countries meet benchmarks for surgical workforce density. 31.5% of countries report adequate surgical volume, with no country-level benchmarks on perioperative mortality. Integrating standardized surgical metrics into health systems is essential […]
Effective Strategies for Malignant Gastric Outlet Obstruction
Endoscopic ultrasound-guided gastrojejunostomy (eus-gj) outperforms surgical methods for malignant gastric outlet obstruction, impacting patient outcomes. EUS-gj shows a clinical success rate significantly higher than surgical gastrojejunostomy (rr 0.82) and enteral stents (rr 0.91). Surgical options are linked to longer hospital stays and increased reintervention rates compared to EUS-gj. Consider recommending EUS-gj as the primary treatment […]
Neoadjuvant Chemotherapy Fails to Outperform Surgery in Colon Cancer
Neoadjuvant chemotherapy does not improve disease-free survival compared to upfront surgery for locally advanced colon cancer, but shows benefits in feasibility and reduced need for adjuvant therapy. Three-year disease-free survival: 87% for upfront surgery vs. 83% for neoadjuvant chemotherapy (p=0.36). Reduced requirement for adjuvant chemotherapy in the neoadjuvant group (59% vs 73%, p=0.02). Surgeons should […]
Medicaid Expansion Linked to Better Outcomes in Pancreatic Cancer
Medicaid expansion improves survival and surgical access for pancreatic cancer patients. Residents in states with early, on-time, and late Medicaid expansion had 2-year mortality reductions (hazard ratios ranging from 0.91 to 0.94). There was a 19% increase in the odds of surgical resection with Medicaid expansion (odds ratio 1.19). Outcomes improved primarily after three years […]